Exploring a new radiation therapy technique for cancer treatment
Research Supplements to Promote Diversity in Health-Related Research: Preclinical optimization of ultra-high dose rate (FLASH) radiotherapy parameters for translational relevance
This study is exploring a new way to give radiation therapy called FLASH, which could help treat cancer more effectively while causing less harm to healthy tissues, and it might be a great option for patients looking for safer treatment alternatives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11063601 on NIH RePORTER |
What this research studies
This research investigates a novel approach to radiation therapy known as ultra-high dose rate (FLASH) radiotherapy, which aims to improve cancer treatment outcomes while minimizing damage to healthy tissues. By delivering radiation at ultra-high rates, the study seeks to maintain effective tumor control similar to conventional methods but with reduced side effects. The research will analyze the effectiveness of FLASH therapy across various organ systems and compare it to traditional radiation techniques, focusing on the dose required to achieve tumor control. Patients may benefit from this innovative treatment if it proves to be more effective and safer than existing options.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who are undergoing radiation therapy and may benefit from improved treatment options.
Not a fit: Patients with non-cancerous conditions or those who are not receiving radiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a breakthrough in cancer treatment that reduces side effects while effectively controlling tumor growth.
How similar studies have performed: Previous studies have shown promising results with FLASH radiotherapy, but this specific comparison of FLASH and conventional dose rates is novel and untested.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Schueler, Emil — University of Tx Md Anderson Can Ctr
- Study coordinator: Schueler, Emil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.